Abstract: A swing arm for a stowable bimini frame associable with a tower structure of watercraft is provided including a body associated with the bimini frame. The body is rotatable relative to the tower structure between a first position and a second position. An engagement mechanism selectively engages the body to retain the body in at least one of the first position and the second position.

Abstract: The invention provides novel compounds having the general formula I: wherein R1, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds, and methods of using the compounds.

Abstract: Compounds of Formula (I): and salts thereof, and methods of use as Janus kinase inhibitors are described herein.

Abstract: The invention provides novel compounds having the general formula I: or pharmaceutically acceptable salts thereof, wherein RA, RB1, RB2, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds, and methods of using the compounds.

Abstract: The invention provides novel compounds having the general formula I: wherein R1, R2, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds and methods of using the compounds.

Abstract: A facility for creating resource graphs based on inherent and derived resource attributes is configured to assist domain experts in the processing and analyses of resource data. The facility obtains input indicating inherent resource attributes and relationships to other the resource attributes. The facility identifies derived resource attributes based on the inherent resource attributes and the relationships to other resource attributes. The facility generates a resource graph based on the derived resource attributes, inherent resource attributes, and the relationships. The facility obtains attributed data from a repository of resource attribute data and evaluates the resource data based on the resource graph and attribute data.

Abstract: The invention provides novel compounds having the general formula I: wherein R1, RB1, RB2, n, p, q, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds, and methods of using the compounds.

Abstract: The invention provides novel compounds having the general formula I: wherein R1, X, Z1, L, n, the A ring, the B ring, and the C ring are as described herein, pharmaceutical compositions including the compounds and methods of using the compounds.

Abstract: The invention provides novel compounds having the general formula I: wherein R1, R2, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds and methods of using the compounds.

Abstract: A facility for creating custom software to analyze resource data is configured to assist domain experts in the creation of custom software. The facility obtains user input indicating one or more global inputs and one or more global outputs. The facility obtains user input creating one or more nodes, each having one or more inputs and one or more outputs, and each configured to evaluate resource data based on the inputs to produce the outputs. The facility obtains user input mapping between outputs and inputs of nodes to establish a network among the nodes. The facility evaluates each node in accordance with the established network based on the global inputs and global outputs. The facility displays the nodes and the network among the nodes.

Abstract: Some embodiments of the invention provide compounds having the general formula I: wherein R1, R2, R3a and R3b are as described herein, pharmaceutical compositions including the compounds, and methods of using the compounds.

Abstract: There is provided soil loosening and furrower assemblies and a bed renovator therefor. The soil loosening assembly comprises a blade assembly and wherein the blade assembly is horizontally pitched such that, when drawn beneath a soil surface at a fixed depth, the horizontally pitched blade assembly severs rootstock at the level of the blade assembly while retaining the rootstock substantially in place and loosens soil above the level of the blade assembly without substantial soil inversion. The furrower assembly comprises side plates extending rearwardly from a forward prow edge, wherein the side plates are approximately 25-45° with respect to the horizontal axis; and bottom edges of the side plates are approximately 20-40° with respect to a direction-of-travel axis.

Abstract: The invention provides novel compounds having the general formula I: wherein R1, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds, and methods of using the compounds.

Abstract: The invention provides novel compounds having the general formula I: wherein R1, R2, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds and methods of using the compounds.

Abstract: The invention provides novel compounds having the general formula I: wherein R1, RB1, RB2, n, p, q, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds, and methods of using the compounds.

Abstract: The invention provides novel compounds having RIP1 kinase inhibitory activity, pharmaceutical compositions including the compounds and methods of using the compounds.

Abstract: Compounds of Formula (I): and salts thereof, and methods of use as Janus kinase inhibitors are described herein.

Abstract: The invention provides novel compounds having the general formula I: wherein R1, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds, and methods of using the compounds.

Abstract: The invention provides novel compounds having the general formula I: wherein R1, X, Z1, L, n, the A ring, the B ring, and the C ring are as described herein, pharmaceutical compositions including the compounds and methods of using the compounds.

Abstract: The invention provides novel compounds having the general formula I: wherein R1, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds, and methods of using the compounds.